An Easy Trade to Make for Profits from Gold Price Volatility

There’s a lot to unpack when it comes to the current analysis of gold and precious metals. As you know, gold tends to be a safe-haven type of investment – something investors turn to when they don’t want their money associated with a certain company or government (bond/currency).

After the Financial Crisis of 2008-2009, gold became an extremely popular investment. For a few years there, it seemed like there was a gold-buying shop on every street corner. Gold was bid up, at least in part, by a massive amount of buying by central banks who wanted to back up their currencies with physical assets.

For the last several years though, gold and other precious metals have been trading at less elevated levels. Then again, with the February 5th meltdown, is it possible metals will become more valuable to investors?

Below is the chart of SPDR Gold Shares ETF (NYSE: GLD), one of the most popular ETFs out there and a very common method for investing in gold. You can see gold did spike during the market meltdown in early February, but has since come back down and is hanging out around the 50-day moving average.

Typically after periods of high volatility, investors start moving more of their portfolio to gold or other precious metals. Yet, in this case, gold lost its luster almost immediately after the market stabilized. Hence, while gold was still a quick buy during the crisis, it hasn’t been holding its own as a safety net after the fact.

Part of the reason could be the lack of any real fundamental concerns among investors. Inflation and tariffs (to some extent) are problems, but they take a long time to actually manifest as true issues. On the other hand, it could be that investors are using cryptocurrencies such as bitcoin as a store of value. After all, bitcoin is entirely decentralized.

So what’s that mean for gold? It’s certainly difficult to pick a clear direction for the precious metal, but it may be not be a stretch to suggest gold is going to move quite a bit from where it is – either up or down.

At least one size options trader believes this could be the case by June expiration. The trader purchased the June GLD 126 straddle (buying both the 126 call and 126 put in June) for $5.30 with the stock just below $126. The trade was executed nearly 2,500 times, so about $1.3 million in premium was paid.

In order to make money, GLD has to be higher than roughly $131 or below $121 by mid-June. Above or below those strikes, the position will generate $250,000 per dollar higher or lower. If GLD is at $126 at expiration, the trader loses the entire premium.

Given the uncertain future of gold as a safe-haven, I think this trade makes a lot of sense. However, I’d prefer to cut down the cost of the trade by doing a strangle instead. The only difference is you’re buying out-of-the-money calls and puts instead of at-the-money options in order to cut costs.

For example, buying the June 123 put and 129 call (the 123-129 strangle) only costs about $3.00. So you’re cutting your premium by almost half. Breakeven points become $120 and $132, do it does widen the targets a bit. Still, I think it’s a reasonable trade off to widen out the breakeven points by a $1 in order to cut almost $2.50 off the premium price. Ultimately, it reduces risk more than it reduces return potential – and that’s clearly a good thing.

  [FREE REPORT] Options Income Blueprint: 3 Proven Strategies to Earn More Cash Today Discover how to grab $577 to $2,175 every 7 days even if you have a small brokerage account or little experience... And it's as simple as using these 3 proven trading strategies for earning extra cash. They’re revealed in my new ebook, Options Income Blueprint: 3 Proven Strategies to Earn Extra Cash Today. You can get it right now absolutely FREE. Click here right now for your free copy and to start pulling in up to $2,175 in extra income every week.

Source: Investors Alley 

The 10 Best Stocks to Invest In Right Now

Source: Shutterstock

It’s a different market than it was just two months ago. Volatility has returned, even if it remains modest relative to historical levels. Big names like Procter & Gamble Co (NYSE:PG) and Walmart Inc (NYSE:WMT), among others, have seen precipitous share price declines just in the past few weeks.

It’s a choppier, more cautious, environment. That’s not a bad thing, however. After a basically uninterrupted post-election rally, several stocks have seen pullbacks that provide more attractive entry points. Others simply haven’t received their due credit from the market.

While there might be reasons for caution overall – higher interest rates, macro concerns – more opportunities exist as well.

This more and more looks like a “stockpicker’s market.” For those stockpickers, here are 10 stocks to buy that look particularly attractive at the moment.

10 Best Stocks to Invest In Right Now: Exxon Mobil

xom stock

Source: Shutterstock

I’m as surprised as anyone that Exxon Mobil Corporation (NYSE:XOM) makes this list. I’ve long been skeptical toward XOM. The internal hedge between upstream and downstream operations makes Exxon stock a surprisingly poor play on higher oil prices. Overall, it leads XOM to stay relatively rangebound – as it has been for basically a decade now.

But price matters, as I argued this week (insert link here if possible). And XOM is at its lowest levels in more than two years after a steady decline since late January. With the dividend over 4% and a sub-16x forward P/E multiple, Exxon Mobil stock looks like a value play. Meanwhile, management is forecasting that earnings can double by 2025, adding a modest growth component to the story.

Obviously, there’s a risk that Exxon management is being too optimistic. Years of underperformance relative to peers like Chevron Corporation (NYSE:CVX) and even BP plc (ADR) (NYSE:BP) has eroded the market’s confidence. If Tesla Inc (NASDAQ:TSLA) can lead a true electric car revolution, that, too, could impact demand and pricing going forward.

At current levels, however, the market is pricing in close to zero chance of Exxon hitting its targets. And that’s why XOM is attractive right now. A continuation of the status quo still gives investors 4%+ income annually. Any improvements in production, or pricing, provide upside. At a two-year low, Exxon doesn’t have to be perfect to see upside in XOM stock.

10 Best Stocks to Invest In Right Now: Nathan’s Famous

Nathan's Hot Dog Eating Contest 2017

Source: Flickr

In this market, recommending a restaurant owner – let alone a hot dog restaurant owner – might seem silly at best. But there’s a strong bull case for Nathan’s Famous, Inc. (NASDAQ:NATH) at the moment.

NATH, too, has seen a sharp pullback of late. The stock touched a 52-week (and all-time) high just shy of $95 in November. It’s since come down about 30%, though roughly one-sixth of the decline can be attributed to a $5 per share special dividend paid in December.

Yet the story hasn’t really changed all that much. Fiscal Q3 earnings in February were solid. The company’s agreement with John Morrell, who manufactures Nathan’s product for retail sale and Sam’s Club operations, offers huge margins, while revenue continues to grow. Foodservice sales similarly are increasing.

The restaurant business has been choppier. But it remains profitable. The mostly-franchised model there is similar to those of Domino’s Pizza, Inc. (NYSE:DPZ) and Yum! Brands, Inc.(NYSE:YUM), among others, all of whom are getting well above-market multiples.

All told, Nathan’s has an attractive licensing model, which leverages revenue growth across the operating businesses. And yet, at 13x EV/EBITDA, and 20x P/FCF, the stock trades at a significant discount to peers. NATH has stabilized over the past few weeks, and Q4 earnings in June could be a catalyst for upside. Investors would do well to buy NATH ahead of that report.

10 Best Stocks to Invest In Right Now: Bank of America

3 Reasons BAC Stock Has More Upside

Source: Shutterstock

Bank of America Corp (NYSE:BAC) trades at its highest level since the financial crisis, and has gained over 150% from July 2016 lows. Trading has been a bit choppier of late – no surprise for a macro-sensitive stock in this market — and there’s a case, perhaps, to wait for a better entry point.

But I’ve liked BAC stock for some time now, and as I wrote last week I don’t see any reason to back off yet. Earnings growth should be solid for the foreseeable future, given rising Fed rates and a strong economy.

BofA itself has executed nicely over the past few years. The company’s credit profile is solid and its stock has outperformed other big banks like Citigroup Inc (NYSE:C) and even JPMorgan Chase & Co. (NYSE:JPM). And tax reform and easing capital restrictions mean a big dividend hike could be on the way as well.

And despite the big run, it’s not as if BAC is expensive. The stock still trades at less than 12x 2019 EPS estimates. Unless the economy turns south quickly, that seems too cheap. So it looks like the big run in Bank of America stock isn’t over yet.

10 Best Stocks to Invest In Right Now: Nutrisystem

Source: Nutrisystem

Nutrisystem Inc. (NASDAQ:NTRI) is another candidate to buy on a pullback. In a disappointing Q4 earnings release at the end of February, Nutrisystem disclosed a rough start to 2018. The beginning of the year is known as “diet season”, a key period for companies like Nutrisystem and  Weight Watchers International, Inc. (NYSE:WTW), as many customers look to act on New Year’s Resolutions.

But marketing missteps led to poor results from Nutrisystem. 2018 guidance now implies basically zero revenue growth – after analysts had projected a 13% increase for the full year.

Still, Nutrisystem is now priced almost as if growth is coming to an end for good. And I as argued at the time, that’s just too pessimistic. The average Street target price still is well above $40, implying over 30% upside. NTRI now trades at under 16x the midpoint of 2018 EPS guidance, and yields over 3%.

The valuation implies that Nutrisystem management is wrong – that 2018’s deceleration is a permanent change. If Nutrisystem management is right – and they’ve earned some credibility in leading revenue and profit to soar over the past few years – then $32 is a far too cheap price for NTRI.

10 Best Stocks to Invest In Right Now: Roku

Why There's a Lot of Volatility Coming for ROKU Stock

Source: Shutterstock

Roku Inc (NASDAQ:ROKU) undoubtedly is the riskiest stock on this list. And there certainly is a case for caution. The company remains unprofitable on even an Adjusted EBITDA basis. A ~7x EV/revenue multiple isn’t cheap; it’s even higher considering that almost half of 2018 revenue will come from the player business, which is a ‘loss leader’ for advertising and platform revenue.

But management also detailed a really interesting future on the Q4 call. The company is looking to build a true content ecosystem – and from a subscriber standpoint, already has surpassed Charter Communications Inc (NASDAQ:CHTR) and trails only AT&T Inc. (NYSE:T) and Comcast Corporation (NASDAQ:CMCSA).

Again, this is a high-risk play – but it’s also a high-reward opportunity. Margins in the platform segment are very attractive, and should allow Roku to turn profitable relatively quickly. International markets remain largely untapped. There’s a case for waiting for a better entry point, or selling puts. But I like ROKU at these levels for the growth/high-risk portion of an investor’s portfolio.

10 Best Stocks to Invest In Right Now: Brunswick

Source: Shutterstock

Brunswick Corporation (NYSE:BC) is due for a breakout. The boat, engine, and fitness equipment manufacturer is nearing resistance around $63 that’s held for close to a year now. Despite a boating sector that has roared of late, BC – the industry leader – has been mostly left out.

Over the last year, smaller manufacturers Marine Products Corp. (NYSE:MPX), Malibu Boats Inc (NASDAQ:MBUU), and MCBC Holdings Inc (NASDAQ:MCFT) have gained 51%, 71%, and 68%, respectively. BC, in contrast, has gained just 2%. It actually trades at a discount to MBUU and MCFT – despite its leadership position and strong earnings growth of late.

Efforts to build out a fitness business have had mixed results, and may support some of the market’s skepticism toward the stock. But Brunswick now is spinning that business off, returning to be a boating pure-play.

Cyclical risk is worth noting, and there are questions as to whether millennials will have the same fervor for boating as their parents. But at 12x EPS, with earnings still growing double-digits, BC is easily worth those risks.

And if the stock finally can break through resistance, a breakout toward $70+ seems likely.

10 Best Stocks to Invest In Right Now: Pfizer

3 Reasons to Be Bullish on PFE Stock

Source: Shutterstock

Few investors like the pharmaceutical space at this point – or even healthcare as a whole. But amidst that negativity, Pfizer Inc. (NYSE:PFE) looks forgotten.

This still is the most valuable drug manufacturer in the world (for now; it’s neck and neck with Novartis AG (ADR) (NYSE:NVS)). It trades at just 12x EPS, a multiple that suggests profits will stay basically flat in perpetuity. To top it off, PFE offers a 3.7% dividend yield.

Obviously, there are risks here. Drug pricing continues to be subject to political scrutiny (though the spotlight seems to have dimmed of late). Revenue growth has flattened out of late. But Pfizer still is growing earnings, with adjusted EPS rising 11% last year and guidance suggesting a similar increase this year. Tom Taulli last month cited three reasons to buy Pfizer stock – and I think he’s got it about right.

10 Best Stocks to Invest In Right Now: Valmont Industries

Source: Shutterstocks

Valmont Industries, Inc. (NYSE:VMI) offers a diversified portfolio – and across the board, business has been relatively weak of late. The irrigation business has been hit by years of declining farm income. Support structures manufactured for utilities and highways have seen choppy demand due to uneven government spending. Mining weakness has had an impact on Valmont’s smaller businesses as well.

Valmont is a cyclical business where the cycles simply haven’t been much in the company’s favor. Yet that should start to change. 5G and increasing wireless usage should help the company’s business with cellular phone companies. Irrigation demand almost has to return at some point. And a possible infrastructure plan from the Trump Administration would benefit Valmont as well.

Concerns about the recently imposed tariffs on steel likely have hit VMI, and sent it back to support below $150. But many of Valmont’s contracts are ‘pass-through’, which limits the direct impact of those higher costs on the company itself. Despite uneven demand, EPS has been growing steadily, and should do so in 2018 as well.

And yet VMI trades at an attractive 16x multiple – a multiple that suggests Valmont is closer to the top of the cycle than the bottom. That seems unlikely to be the case, and as earnings grow and the multiple expands, VMI has a clear path to upside.

10 Best Stocks to Invest In Right Now: American Eagle Outfitters

Is It Worth Chasing the Rally in AEO Stock?

American Eagle Outfitters (NYSE:AEO) is one of the, if not the, best stocks in retail – and that’s kind of the problem. Mall retailing, in particular, has been a very tough space over the past few years. And it’s not just the impact of Amazon.com, Inc. (NASDAQ:AMZN) and other online retailers. Traffic continues to decline, which pressures sales and has led to intense competition on price, hurting margins.

But American Eagle has survived rather well so far, keeping comps positive and earnings stable. And yet this stock, too, trades at around 12x EPS, backing out its net cash. And American Eagle has an ace in the hole: its aerie line, which continues to grow at a breakneck pace. aerie brand comparable sales rose 27% in fiscal 2017, on top of a 23% rise the year before.

The company’s bralettes and other products clearly are taking share from L Brands Inc(NYSE:LB) unit Victoria’s Secret. And the e-commerce growth in that business, and for American Eagle as a whole, suggests an ability to dodge the intense pressure on mall-based retailers.

In short, American Eagle isn’t going anywhere. There’s enough here to suggest American Eagle can eke out some growth, and a 2.5% dividend provides income in the meantime.

The stock already is recovering from a post-earnings sell-off last week, and should continue to do so. And longer-term, there’s still room for consistent growth, and more upside.

10 Best Stocks to Invest In Right Now: United Parcel Service

Source: UPS

United Parcel Service, Inc. (NYSE:UPS) fell when the broad market did in February – and simply never recovered. A disappointing Q4 earnings report, in which investors saw signs of higher spending, drove some of the decline. But UPS stock wound up falling 22% in a matter of weeks – which looks like an unjustified sell-off.

UPS is going to have to spend to add capacity, and in this space too there’s the ever-present threat of Amazon. But UPS is an entrenched leader, along with rival FedEx Corporation(NYSE:FDX), and it at worst can co-exist with Amazon. E-commerce growth overall should continue to increase demand; there’s enough room for multiple players in the global market.

Meanwhile, the sell-off and benefits from tax reform mean that UPS now is trading at just 15x the midpoint of its guidance for 2018. And the stock yields a healthy 3.3%. Investors clearly see a risk that growth will decelerate, but UPS stock is priced as if that deceleration is guaranteed.

  [FREE REPORT] Options Income Blueprint: 3 Proven Strategies to Earn More Cash Today Discover how to grab $577 to $2,175 every 7 days even if you have a small brokerage account or little experience... And it's as simple as using these 3 proven trading strategies for earning extra cash. They’re revealed in my new ebook, Options Income Blueprint: 3 Proven Strategies to Earn Extra Cash Today. You can get it right now absolutely FREE. Click here right now for your free copy and to start pulling in up to $2,175 in extra income every week.

Trump’s Trade War Set to Cost This Automaker $1 Billion: Sell Now

If you like a good war, you’re living in the right era.

You don’t have to look far before you hear about a war on something.

War on crime. War on drugs. And outright war itself.

Now we’re facing another one.

News that the United States will slap a 25% tariff on steel imports and 10% on aluminum imports has triggered fears of a global trade war.

European Commission President Jean-Claude Juncker set the tone by saying that the EU will be forced to retaliate to the “stupid process” by imposing tariffs of its own on exported U.S. goods. “We can also do stupid. We have to be this stupid,” as he put it.

Adding duty to such crucial raw materials from abroad should bode well for U.S. steel and aluminum manufacturers – and their respective workforces. But it will also reduce global supplies and consequently push up prices for end users. In turn, those costs will be passed down to consumers.

When you think of the amount of steel and aluminum used in products, many sectors and industries will suffer. Chief among them are ones like construction and transportation.

Indeed, the auto industry accounted for over one-quarter of U.S. steel demand last year, according to Statista. And the American International Automobile Dealers Association has already said the tariffs will result in higher car prices and lower sales.

That’s bad news for big, multinational U.S. automakers like Ford Motor Co. (NYSE: F).

Speed Bumps Ahead for Ford

Right off the bat, the stock is down 11.3% year-to-date. But the losses extend further back than that. Since July 2014, shares have tumbled steadily, falling 39%.

Other recent developments don’t bode well, either.

Sales Down: Nationwide, total auto sales fell by 2% in 2017. And while overall year-over-year sales were up 1% in January, Ford didn’t join the party, with sales down 6.6%. The climate got worse in February, with total nationwide sales dropping by 2% and Ford’s sales slumping by 6.8%. A 12.3% plunge in higher-end SUV sales marked the fall. Some analysts feel auto sales peaked in 2017. The fact that Ford’s shares still didn’t rise as a result back then – and its sales are now lagging significantly – is an ominous sign.

Interest Up: Another red flag is the fact that the price of a new car rose by 2% in February, to $35,444, according to Kelley Blue Book. Not only that, interest rates on car payments (both new purchases and leases) are rising, too. Edmunds says the APR averaged 5.2% in February – up from 4.9% a year ago and from 4.4% in February 2013. They’re now at the highest levels since 2010. Rising car prices and interest rates aren’t exactly a good combination for automobile manufacturers trying to boost sales numbers.

As if this climate weren’t challenging enough, Ford and other conventional automakers are also facing pressure from the increasing shift towards ride-sharing and electric cars.

And now, in addition to these headwinds, is the specter of trade tariffs. UBS says higher raw materials prices could cost Ford an extra $300 million this year, with Goldman Sachs warning it could hit the company’s operating profit by $1 billion. Keep in mind, Ford’s operating margin isn’t great anyway – just 4.3%.

Add it all up, and you’ve got a nasty cocktail for Ford: Falling auto sales, higher sales prices, rising interest rates on car payments that’s deterring consumers from new purchases, the shift towards ride-sharing and electric cars, plus steel and aluminum tariffs adding to retail prices.

Oh, and a stock that’s gone nowhere but down for almost four years now.

Give Ford a wide berth.

Buffett just went all-in on THIS new asset. Will you?
Buffett could see this new asset run 2,524% in 2018. And he's not the only one... Mark Cuban says "it's the most exciting thing I've ever seen." Mark Zuckerberg threw down $19 billion to get a piece... Bill Gates wagered $26 billion trying to control it...
What is it?
It's not gold, crypto or any mainstream investment. But these mega-billionaires have bet the farm it's about to be the most valuable asset on Earth. Wall Street and the financial media have no clue what's about to happen...And if you act fast, you could earn as much as 2,524% before the year is up.
Click here to find out what it is.

Source: Investors Alley

This Math Is Magic

 


Dear Early Investor,

Last week, I told you about how adding a technical analysis layer to my stock vetting made me a much better investor.

This week, I’m going to share with you how I do it.

Of course, I can’t tell you everything in one short article. My partner Adam has already discussed a neat technical analysis tool called the relative strength index. Read his piece here if you haven’t already. It’s definitely worth a few minutes of your time.

Today, I’ll be discussing another neat tool: Fibonacci retracements.

It’s not the only tool I use. In fact, Fibonacci is most effective when used with other technical indicators. But it’s definitely one I like a lot.

For one, it’s versatile. It can help predict the extent of both pullbacks and rallies.

So what exactly are Fibonacci retracements?

They’re ratios that indicate when price reversals may be drawing near.

What this means is when a price line hits these levels, it signals a possible turnaround. When other technical indicators also point to a turnaround at the same time, the signal is amplified.

The most common Fibonacci ratios are 23.6%, 38.2% and 61.8%. (You’ll also see a 50% level with most Fibonacci charts – though technically, it’s not a part of the Fibonacci sequence.)

Curious as to where these ratios come from?

Well, we have to go back nearly a thousand years to identify their origins.

Leonardo Pisano Bigollo (aka Fibonacci) was a mathematician from Pisa who introduced the Fibonacci sequence to the West in the 12th century. It is as follows: 0, 1, 1, 2, 3, 5, 8, 13, 21, 34, 55, 89, 144, 233, 377, 610… and so on to infinity.

Fibonacci demonstrated how a number divided by the previous number in his sequence approximates 1.618. And, lo and behold, a number divided by the next highest number approximates 0.6180.

It’s known as the “golden ratio,” and it is the ratio I consider the most important. (By the way, the inverse of 1.618 is approximately 0.618!)

What I find fascinating is that these ratios are also found throughout nature, architecture, art and biology. They can be seen in everything from sunflowers to the spirals in galaxies.

The next most significant number? It’s 0.3820.

It’s the number you get when you take one of Fibonacci’s sequence numbers and divide it by another one two places higher. For example: 13/34 = .382. (Also note that 1 – .618 = .382.)

Years ago, I used these ratios for stock price analysis. Now I’m back at it, using them to help predict crypto price movements. It’s like meeting an old friend!

They’re called retracement levels (or ratios) because they refer to price movements that retrace in the opposite direction of a previous leg up or down.

As the bounce or correction approaches these retracement levels, technical analysts become increasingly aware of a possible price reversal, especially when other indicators are chiming in.

To illustrate just how Fibonacci works, I’m going to show you three bitcoin charts. For purposes of clarity, I’m not including other technical indicators, so keep in mind these charts have been simplified to an extent.

After a long climb, bitcoin finally peaked last December and began retracing some of the gains it previously made.

But by how much?

Remember, I said that 61.8% was the level I paid most attention to. You’ll notice in the chart that once prices broke below that important level, they immediately began a new leg up.

What can you do with this information?

When others may be thinking of selling, you’re thinking of buying on the dip. At the very least, it prevents you from selling at the wrong time.

Here’s another bitcoin chart using the Fibonacci levels from earlier, identifying a smaller leg up from last September…

As prices approach the 61.8% level, the possibility of a price reversal once again presents itself.

And another buying opportunity is indicated in advance using the Fibonacci levels.

So what about right now?

What can the Fibonacci levels tell us about current price movements?

With prices just shy of the 61.8% level, they say that a rally could be imminent.

A couple of things to remember here…

While Fibonacci puts me on the alert for a price reversal, I like to see it actually happening before issuing a buy or sell alert. And, as I’ve said, I like to see other indicators supporting what Fibonacci is telling me.

As I mentioned last week, we’re dealing in probabilities here, not certainties. So even though I now have a technical system in place (I call it the “Cadillac of technical analysis systems”) telling me how much lower prices need to go for an upswing to occur, there are no guarantees.

Nonetheless, these kinds of technical analysis tools go a long way in helping me understand price trends and manage risk.

We’now better equipped to give our members insightful buy and sell guidance so they can optimize gains, minimize losses and, at the end of the day, show greater overall crypto profits.

Soon, in our Crypto Asset Strategies service, we’ll focus much more on using technical analysis like this to help us vet new crypto recommendations. If this kind of approach interests you, be sure to keep a close eye on our upcoming alerts.

Good investing,

Andy Gordon
Co-Founder, Early Investing

The 145 Companies Your Stockbroker Will NEVER Tell You About Did you know more than 145 tiny companies have grown to $1 billion-plus valuations since 2012? SpaceX  is up 26,309% in value... Dropbox 31,733%... and Pinterest 487,404%. All of these 145 businesses started out as private companies your broker would have NEVER told you about. But now there’s a great way to find the next private companies poised for hyper-growth. Full Details Here.

Source: Early Investing 

5 ‘Strong Buy’ Biotechs That Can Double in 2018

Source: Shutterstock

According to top analysts on the Street, these five “Strong Buy” biotech stocks are primed for outsized growth in the next 12 months.

Biotechs often present intriguing, and potentially lucrative, investment opportunities. Share prices can explode on positive trial results or key regulatory approvals. However, buyers beware: These rewards can disappear just as quickly if critical data disappoints. To minimize this risk, we specifically searched for stocks with a high degree of confidence from Wall Street’s top analysts.

In this case, we used the popular Trending Stocks tool to filter for best-rated stocks in the last week, regardless of market capitalization. The best part about this tool is that it clearly displays the upside potential from the current share price to the average analyst price target.

So we crunched the data and pinpointed these five compelling biotech stocks that are trending right now. All five stocks share a bullish Strong Buy analyst consensus rating. Note that this is based only on analyst ratings from the last three months.

With this in mind, let’s delve deeper into why the Street is so bullish on these stocks right now:

Strong Buy Biotech: TG Therapeutics (TGTX)

Strong Buy Biotech: TherapeuticsMD (TXMD)

Source: Shutterstock

TG Therapeutics, Inc. (NASDAQ:TGTX) is focused on the development of novel treatments for B-cell malignancies and autoimmune diseases. Following strong Q4 results, five-star HC Wainwright analyst Edward White ramped up his price target from $33 to $38 (130% upside potential) on March 8.

His reasoning for the valuation is a bit complex, but ultimately it is based on the success and potential revenue of the company’s two main drugs ublituximab and umbralisib. Both are currently in Phase 3 clinical development. White explains: “We use the net present value of our revenue forecast through 2026, apply a 55% probability of success (POS) for ublituximab in CLL (Chronic Lymphocytic Leukemia), a 45% POS for umbralisib in CLL, and a 25% POS for both ublituximab and umbralisib in NHL (Non-Hodgkin Lymphoma), to arrive at our $38 price target.”

Bear in mind that so far White has struck gold with his TGTX recommendations. Across his 20 ratings on the stock he scored a 90% success rate and 44.4% average return. Meanwhile B.Riley FBR’s Madhu Kumar selects TGTX as an Out the Gate 2018 Pick, due to his “reasonable confidence in success in the Phase III UNITY-CLL trial, with interim data expected in 2Q18.”

In the last three months, four analysts have published buy ratings on TGTX. No hold or sell ratings here. And with an average analyst price target of $27.50, on average analysts are predicting 67% upside from the current share price.

Strong Buy Biotech: TherapeuticsMD (TXMD)

Strong Buy Biotech: TherapeuticsMD (TXMD)

Source: Shutterstock

Innovative women’s healthcare company, TherapeuticsMD, Inc. (NYSE:TXMD), is launching important therapies for menopause-associated conditions. The company has just scored a big regulatory win. On March 8, the FDA announced that it is accepting an NDA (new drug application) for TX-001HR without noting any ‘potential review issues.’ Now the key date to keep an eye on is Oct. 28, 2018, when the FDA will either approve or reject the application.

“We view the revenue opportunity for TX-001 (hot flushes of menopause) to be several times larger than that for TX-004 and believe prevailing compounding regulations and compounder willingness to prescribe branded drugs could benefit TXMD” states top Cantor Fitzgerald analyst William Tanner. He sees the stock spiking a whopping 400% to hit $28 from the current share price of just $5.50.

In the meantime, TXMD’s other pipeline product, TX-004, has its approval date on May 29. This is a critical barometer for the success of TX-001 according to Tanner. He says: “we view the importance of the FDA’s action around that date to be of Brobdingnagian proportion.” This is because any response short of approval will lead to stock selling.

Bear in mind, the stock has unanimous support from the Street. In the last three months five analysts have published buy ratings on TXMD. Their average price target of $15.50 works out at 190% upside from the current share price of just $5.35. 

Strong Buy Biotech: Clearside Biomedical (CLSD)

Strong Buy Biotech: Clearside Biomedical (CLSD)

Source: Shutterstock

Clearside Biomedical, Inc. (NASDAQ:CLSD) develops first-in-class drug therapies to treat blinding eye diseases. The stock is already up by a massive 80% year-to-date. Shares surged from just above $6 at the end of February to over $14 at the beginning of March. The catalyst: positive results in a late-stage trial to improve vision in patients with back of the eye swelling – otherwise known as macular edema.

The company revealed that 47% of patients administered the suprachoroidal CLS-TA treatment, could see at least 15 letters, compared to just 16% for patients with the placebo. CLSD now plans to file a marketing application with the FDA in Q4.

But don’t worry it’s not too late to profit from the stock’s meteoric rise. Top Wedbush analyst Liana Moussatos has just ramped up her price target to $29 on the news. This indicates further upside potential of 137%. She believes the results further validate CLSD’s micro-injection technology.

Moussatos commented, “In addition to several positive Phase 2 trials in ME-NIU, ME-RVO and DME, the PEACHTREE trial results represent the first clinical success at the Phase 3 level. Vision gain from suprachoroidal CLS-TA was observed as early as 30 days and maintained throughout the 6-month study. Due to the strength of the Phase 3 results, we consider clinical risk for the pipeline to be reduced.”

Overall, CLSD boasts six back-to-back buy ratings. Analysts (on average) see the stock soaring 80% to hit $22.80 in the coming months.

Strong Buy Biotech: Ocular Therapeutix (OCUL)

Strong Buy Biotech: Ocular Therapeutix (OCUL)

Source: Shutterstock

Why have one eye drug company when you can have two?! Ocular Therapeutix, Inc.(NASDAQ:OCUL) has a clear goal: to pioneer a new era of drug delivery in ophthalmology. OCUL is currently trading at a bargain price of just $6.37. However, analysts are projecting big upside potential of 115% in the coming months. The company has received three buy ratings in the last three months.

Right now, OCUL has 1 approved product (ReSure Sealant for cataract incision closure) and 6 pipeline products. The big hitter here is Dextenza for the treatment of post-surgery eye pain and inflammation. Although the FDA rejected the drug’s first new drug application (NDA), everything is now on track for resubmission in the first half of 2018. The company has worked closely with the FDA to resolve all the issues. Luckily for OCUL, the FDA’s comments have not required any substantial change in its manufacturing or regulatory plans.

On this basis, five-star BTIG analyst Dane Leone sees Dextenza obtaining US regulatory approval by the end of 2018. The upshot is potential market entry for the drug as early as 2019. And from a financial perspective, the company raised $37 million additional capital in January, which provides a cash runway well into 2019.

Strong Buy Biotech: Flex Pharma (FLKS)

Strong Buy Biotech: Flex Pharma (FLKS)

Source: Shutterstock

Last but not least comes ‘Strong Buy’ stock Flex Pharma, Inc. (NASDAQ:FLKS). Flex develops treatments for cramps and spasms associated with severe neurological diseases including ALS, MS and CMT (Charcot–Marie–Tooth disease).

Top HC Wainwright analyst Andrew Fein has just reiterated his Flex buy-rating with a very bullish $40 price target. Given that the stock is currently trading at just $5, this indicates huge upside potential of over 680%. He is confident in the ‘mechanistic rational’ of the company’s spasm reduction FLX-787 therapy.

“Catalysts on deck in MS, ALS, and CMT may provide near-term inflection points” according to Fein. Prepare for the read-out data from FLX-787’s exploratory Phase 2 spasticity study in multiple sclerosis to hit later this month. Later down the line, in early 2019, investors are looking to results from two Phase 2 trials in patients with ALS and CMT.

“All these activities in the pipeline may provide near-term inflection points, and signal to us that the company is making solid strides, and is committed, to transitioning into a pharmaceutical company from a consumer company” cheered Fein on March 8.

Flex boasts four recent buy ratings with just 1 analyst sticking to the sidelines. The $17.50 average analyst price target is over 200% from the current share price.

Buffett just went all-in on THIS new asset. Will you?
Buffett could see this new asset run 2,524% in 2018. And he's not the only one... Mark Cuban says "it's the most exciting thing I've ever seen." Mark Zuckerberg threw down $19 billion to get a piece... Bill Gates wagered $26 billion trying to control it...
What is it?
It's not gold, crypto or any mainstream investment. But these mega-billionaires have bet the farm it's about to be the most valuable asset on Earth. Wall Street and the financial media have no clue what's about to happen...And if you act fast, you could earn as much as 2,524% before the year is up.
Click here to find out what it is.

ETF Traders Are Giving You These 3 High-Yield Stocks at a Discount

For investors who own individual dividend paying stock, it has become difficult to see why share prices move as they do. You probably know the feeling of having one of your stocks make a big move —usually down—and you cannot see any reason for the stock price action. Much of the blame for wild stock swings can be laid at the feet of exchange traded funds and the traders who short-term trade ETFs.

An ETF owns shares of stock to match the components of a specific stock index. For example, the SPDR S&P 500 ETF (NYSE: SPY) owns the 500 stocks in the same proportion as tracked by the Standard & Poor’s 500 stock index. The financial products industry has gone nuts with the development of new indexes to carve up the market into sectors and ETFs to track them. Currently there are over 2,000 ETFs listed in the U.S. The majority —78% of assets—of ETFs are based on stock market indexes. Those assets total over $2.4 trillion. ETF trading has become a very big part of what goes on in the stock markets.

There are two ways ETF action can affect the share values of individual stocks. The most obvious and easy to discern is when the weighting of a stock in an index is changed. One high yield example is Energy Transfer Partners LP (NYSE: ETP), a large cap master limited partnership, commonly abbreviated as MLP. In April 2017 ETP completed a merger with Sunoco Logistics Partners LP, another MLP that was a large component of MLP indexes. Because of the merger, ETFs and index funds tracking MLP indexes were forced to sell significant portions of their ETP holdings to bring the size of the positions down to match the index weightings. This merger was the start of a year long decline in the ETP unit value. Later in 2017, Alerian, the provider of the most popular MLP tracking indexes, changed its methodology to cap Alerian MLP Index constituents to a 10% weight. At that time, ETP’s weight was much higher than 10% in the index, so index tracking funds were again forced to sell ETP units, regardless of investment merit. These forced sales of ETP are the source of much of the 25% value decline over the past year. The company’s fundamentals have been steadily improving, but you could not tell by the market price. ETP currently yields 12.5%.

Related: 3 Growth ETFs for High Yield and Diversification

A subtler effect of the ETF boom is that trading of these funds leads to lack of discrimination between the financial results and business prospects. Stocks get lumped together into the ETFs that track specific market sectors. It is tough to figure out whether stock share prices and ETF trading are a chicken and egg dilemma, but it is becoming clearer that increases in ETF trading are tightening correlations, or the tendency for individual stocks and sectors to move up or down in lock step, regardless of a company’s fundamentals. While ETFs account for about 8% of the U.S. stock market value, ETFs are the source of more than 25% of the trading volume. Market observation clearly shows that share prices are greatly affected by short term sector switching by traders. The iShares Mortgage Real Estate ETF (NYSE: REM) provides a couple of examples. Most of the 30 or so stocks in this ETF own leveraged portfolios of residential mortgage backed securities, MBS in industry parlance. This business model is a dangerous game of lending long and borrowing short. This is a group of companies whose finances can be destroyed by a quick change in the yield curve. I recommend against owning any residential MBS focused REITs.

In contrast, the third and fourth heavily weighted stocks in REM are solid companies with business operations that are sustainable through market cycles. In contrast to the rest of the REM portfolio stocks, these two will do even better when short term rates rise. Starwood Property Trust, Inc. (NYSE: STWD) and New Residential Investment Corp (NYSE: NRZ) are very attractive stocks with share prices that have trouble escaping from the trading in REM. STWD currently yields 9% and NRZ is over 11%.

Get up to 14 dividend paychecks per month from safe, reliable stocks with The Monthly Dividend Paycheck Calendar, an easy-to-use system that shows you which dividend stocks to pick, when to buy them, when you get paid your dividends, and how much.  All you have to do is buy the stocks you like and tell them where to send your dividend payments. For more information Click Here.


Source: Investors Alley 

3 Funds Paying Up to 12% and Set to Rip Higher

The big rebound is on! But don’t worry, your opportunity to grab big gains (and dividends) hasn’t evaporated.

There’s still time!

And you can start with 3 of the 4 funds I pounded the table on back on February 19. At the time, all 4 of these cheap selloff buys were paying a combined 13.4% income stream.

So why are just 3 of these funds still worthy of your attention, only a few weeks later?

I’ll unpack that—and name these 3 top-flight funds—in a moment. First, let’s step back and take a look at what happened in a very wild February, and where it all leaves us now.

A Market Disaster Gets Undone

So much has happened. First, the S&P 500 (SPY) did this:

Was It All a Dream?

The good news is, the stock market losses we saw at the start of the month are now history.

The even better news is that the S&P 500 is up just over 3% from the start of 2018, meaning this market isn’t overheated. That “goldilocks” position should be giving investors more confidence that now is the right time to get back into the game.

It also means time is running out if you haven’t gotten back in already.

And if you’re sitting on cash?

No problem. I’ll show you where to put that cash to work without overpaying too much for the wrong investments.

But before I get to that, let’s take a look at those 4 funds I earmarked in February. They were the PCM Fund (PCM), the Virtus Global Multi-Sector Income Fund (VGI), the Kayne Anderson MLP Investment Company (KYN) and the Dreyfus Strategic Municipal Bond Fund (DSM).

How do these funds look now?

A Quick Improvement

While the warm weather—and a corresponding drop in natural gas and heating oil demand—has weighed on the master limited partnership–focused Kayne Anderson fund, the average return for these picks since I pointed them out, about two weeks ago, is 2.7%, while the S&P 500 is down slightly since then.

In other words, if you’ve heard that buying a low-fee index fund is the right thing to do, just take a look at that chart.

So What Now?

To determine which of these funds remain compelling options, we need to look at their discount to net asset value.

This is where we compare the market price for these funds, which trade daily like normal stocks, and their NAV, which is based on the market price of every item in their portfolios.

Now you’d think an efficient market would make these two figures the same, right? Wrong!

That’s because these are closed-end funds, a little-known corner of the market that’s worth around $300 billion, compared to the multi-trillion-dollar mutual fund and ETF universes. (If you’re unfamiliar with CEFs, click here for an easy-to-follow primer I recently wrote on these cash machines.)

The small size of the CEF market means a lot of big investors who could profit from these inefficiencies don’t bother—and it also means a lot of mom-and-pop investors don’t know these funds even exist.

That’s our opportunity.

The 4 funds I’ve shown you are all CEFs, and, of course, none of them are trading at their NAV (although two do come close):

3 Bargains—and 1 Ship That’s Sailed

First, let’s tackle the PCM Fund, which trades at a 9.8% premium to its NAV, meaning it’s priced above the actual market value of its portfolio. That’s because PIMCO, the fund manager, is great at beating the market, so the market rewards them with a premium.

But a near double-digit premium is too rich for my blood, so this isn’t the best fund to buy right now. And if you nabbed PCM at its unusually low premium earlier in February, you might want to consider getting out or, at the very least, holding on and allocating cash to other investments.

Meanwhile, the Dreyfus Strategic Municipal Bond Fund sports a discount to NAV that has widened since my February 19 article—but investors haven’t really lost any money since I recommended it. How is that possible?

Simple: the fund’s price has slid, but the NAV is staying straight.

Stable NAV, Lower Price

And since investors are still getting the fund’s 5.5% dividend yield, they’re pocketing a strong income stream while they hold on. And since it’s gotten even cheaper, despite the fact that the fund’s real, intrinsic value hasn’t changed, it’s something worth considering if you have cash to spare.

Now let’s hit the Virtus Global Multi-Sector Income Fund and the Kayne Anderson MLP Investment Company. Both funds are trading close to their NAV, and both are paying massive dividends—12% and 10.6%, respectively. So should income investors hold on or buy more?

To answer that question, we’ll take a look at this chart showing where their discounts to NAV stand relative to history:

The Big Picture

This chart makes one thing clear: KYN is now cheaper than it’s been through most of its history, where it tends to trade at a premium to NAV. On the other hand, VGI’s discount, while off a bit from the last few months, is narrower than it usually is.

That makes one thing clear: buying more KYN and waiting for it to revert to its historical mean looks like a smart move, while cautiously adding VGI is also practical, since it’s a strong fund with a very good portfolio.

So if you’re sitting on cash, 3 of these funds still deserve your attention. And thanks to the 500-strong CEF market, there are a lot more out there, too—starting with the 14 I want to tell you about now.

One Click for the 14 Best Funds of 2018

That’s right—you can skim right through all the 500 or so CEFs in the world with just one click and go straight to the 15 funds with the highest yields and biggest gains ahead in 2018 (I’m talking SAFE dividends up to 9.6% and double-digit upside).

All you need is a no-risk 60-day trial to my CEF Insider service. And your timing is perfect, because I’m making a limited number of these trial memberships available now!

Simply CLICK HERE to start your no-obligation trial. When you do, you’ll get instant access to the names, tickers and my complete research on each and every one of the 15 cash machines in the CEF Insider portfolio.

These 15 bargain CEFs all trade at absurd discounts to NAV that are slowly narrowing. That puts unrelenting upward pressure on their share prices and sets us up for a market-crushing gain in 2018!

But the best part—by far—is the dividends.

Right now, the portfolio boasts an average yield of 7.4%. But remember, that’s just the average! Cherry-pick my 3 highest-yielding funds and you’ll be pocketing life-changing payouts like 9.6%, 9.55% and 9.0%!

I hope you’ll take this opportunity to join the small group of investors across the country who are pocketing regular monthly dividend checks from these 15 terrific funds.

Please don't make this huge dividend mistake... If you are currently investing in dividend stocks – or even if you think you MIGHT invest in any dividend stocks over the next several months – then please take a few minutes to read this urgent new report. Not only could it prevent you from making a huge mistake related to income investing, it could also help you earn 12% a year from here on out! Click here to get the full story right away. 

Source: Contrarian Outlook 

My 7 Must-Own Stocks to Build Up Your Retirement

Source: Shutterstock

I have a completely different philosophy for retirement stocks than virtually anybody else in the financial markets.

The prevailing wisdom is to overweight in bonds in order to generate income and to allegedly reduce volatility in the overall portfolio. That’s horrible advice, mostly because bonds and bond funds are actually more volatile than stocks are.

The other terrible advice that is given to current and pending retirees is that retirement investors should plow money into blue-chip stocks that pay dividends of 2% to 3%.

That is also terrible advice because ever since the Federal Reserve reduced yields, a lot of retirement investors have moved further out on the risk curve into exactly these stocks, bidding them up to levels that are unsustainable.

The stocks are more likely to fall in the next few years by substantial amounts, more than enough to wipe out whatever dividends are being paid. That’s why I chose a particular set of stocks, ones that go against the standard retirement grain, but that should be in your portfolio.

Must-Own Retirement Stocks: United Parcel Service (UPS)

Source: UPS

United Parcel Service (NYSE:UPS) is about as close to a no-brainer in the category of retirement stocks as you can get. It’s always great to have stocks that are part of an oligopoly in your portfolio, especially if they been around a very long time, and have a very good track record.

UPS represents a core business of the human experience. People will always need to send things around the globe, and are only so many companies with a broad enough reach to do that. It pays a very respectable 3 BA stock should continue to do well for quite some time .44% yield.

Must-Own Retirement Stocks: Boeing (BA)

The Boeing Company (NYSE:BA) is another company that falls into the oligopoly category for retirement stocks. There are a limited number of companies that actually manufacture airplanes to begin with, and very few companies that have the breadth of experience in defense contracting.

BA has been in business for 100 years and its expertise in defense, space, security, and airlines is unparalleled.

With an administration that places a high value on defense, Boeing will do well for quite some time, and the $5.68 in dividend payments every year as an added bonus.

Must-Own Retirement Stocks: Visa (V)

Visa, Inc. (NYSE:V) is yet another company in the same theme of oligopolies for retirement stocks. There are very few credit card processing companies in the world, and Visa has the largest market share out of any of them.

With financial services becoming more and more impactful in the global economy, and consumers needing an increasing number of payment solutions, Visa will be at the top of the class for a very long time.

It generates a tremendous amount of free cash flow and, in fact, has so much that he could afford to raise its dividend significantly.

Must-Own Retirement Stocks: Exxon (XOM)

Exxon Mobil Stock's Big Profit-Growth Target Fails to Impress Investors

Source: Shutterstock

Exxon Mobil Corporation (NYSE:XOM) belongs to a category of retirement stocks that I also considered to be core holdings for just about any portfolio. You must have fossil fuel energy companies represented in some way in your portfolio.

Energy is a central component of the human experience. Look around you every single thing has been brought to your location by a vehicle that required fossil fuels to transport them.

Not to mention whatever was needed to create the products in the first place, such as plastics. Beyond that, of course, energy is what makes the world move.

Exxon Mobil happens to be substantially undervalued at this time.

Must-Own Retirement Stocks: AT&T (T)

AT&T Inc. (NYSE:T) might not have made my list several years ago, despite the fact that it is a dividend aristocrat that has been increasing dividends every year for more than 25 years.

That’s mostly because organic growth is a telecom company had been slowing. But then it purchased DirecTV, and is now becoming a content play with its proposed Time Warner Inc. (NYSE:TWX) merger.

I do believe the merger will go through is I don’t believe the Department of Justice has a viable case.

Must-Own Retirement Stocks: Disney (DIS)

Walt Disney Co Stock Is Due for a Magical Run Higher

Source: Shutterstock

The Walt Disney Company (NYSE:DIS) is the premier media and entertainment company in the world. As it is, it owns three extraordinary properties in Marvel Studios, Lucasfilm and Pixar films.

That says nothing about its own incredibly successful studio. Put all this together with the assets it hopes to acquire in the buyout of Twenty-First Century Fox Inc. (NASDAQ:FOXA), and Disney will have enough content that will literally last a generation and probably longer.

The theme parks and resorts have become a staple of tourism, and one that is constantly innovating and redefining itself.

Must-Own Retirement Stocks: Duke (DUK)

Duke Energy Corp (NYSE:DUK)

Source: Shutterstock

Duke Energy (NYSE:DUK) is a massive utility that stretches through the Southeast and Midwest. The wonderful thing about utility stocks is that they are regulated.

That means that the utility has a very clear idea of how much revenue it will generate every year, and therefore what kind of costs it can generate in order to not only remain profitable but pay a regular dividend.

Speaking of that dividend, Duke has been paying it every quarter for 91 years.

As of this writing, Lawrence Meyers did not hold a position in any of the aforementioned securities.

Get up to 14 dividend paychecks per month from safe, reliable stocks with The Monthly Dividend Paycheck Calendar, an easy-to-use system that shows you which dividend stocks to pick, when to buy them, when you get paid your dividends, and how much.  All you have to do is buy the stocks you like and tell them where to send your dividend payments. For more information Click Here.


Source: Investor Place 

Buy These 3 Stocks for the Boom in American Oil Exports

Monthly oil output in the U.S. this year topped 10 million barrels a day for the first time since 1970, hitting all-time records. And the surge has just begun.

On March 5, the International Energy Agency (IEA) released its forecast that predicted U.S. shale output would rise by 2.7 million barrels a day to 12.1 million barrels per day by 2023. As the IEA’s executive director, Fatih Birol said in a statement, “The United States is set to put its stamp on global oil markets for the next five years.”

(Of that 16 million in 2023 the IEA projects that 12 million will come from shale)

U.S. Oil Exports

Importantly, Birol expects U.S. oil exporting capacity to more than double over the next five years from 1.9 million barrels late last year to 4.9 million barrels per day by 2023. That’s a good thing. Let me explain…

First, additional domestic demand for shale (mainly from the petrochemicals industry) will be around 900,000 barrels a day, according to an estimate from the energy research firm Wood Mackenzie. That’s not close to sopping up the extra oil produced.

An even bigger factor is the U.S. oil refining system, which was built many years ago. It runs much more efficiently on a steady diet of heavier, more sulfurous oil such as oil that comes from many OPEC countries. U.S. shale oil is mostly a light, ‘sweet’ crude oil variety.

Bottom line – a lot of the additional oil produced must find a market overseas, such as Europe or China. That’s just another reason a trade war is not a good idea. And why it was a good idea to remove the decades-old restriction on the export of U.S. crude oil in late 2015. U.S. exports of crude oil and petroleum products climbed more than 1.7 million barrels per day between December 2016 and December 2017 to a record 7.3 million barrels a day.

A key and often overlooked component to the expected surge of exports of U.S. shale oil is infrastructure. Important pieces of the needed infrastructure are our ports. One such facility is the Louisiana Offshore Oil Port (LOOP), which has been converted from a massive import facility. Just last month it test-loaded an oil supertanker for the first oil exports in its 37-year history.

Other pieces of our crucial energy infrastructure are our pipelines. It is this crucial infrastructure that gives U.S. oil exports a structural advantage by cutting the cost of moving oil from the oil fields to ports. For example, the price difference between oil sold at Midland, Texas, in the middle of the prolific Permian Basin, and equivalent grades of oil on the Gulf Coast have narrowed from more than $30 a barrel in 2012 to just $3 as new pipeline flows have come onstream.

Oil Pipelines Point South

The U.S. pipeline infrastructure is undergoing a drastic change at the moment as the focus shifts to delivering as much shale oil as possible to Gulf of Mexico terminals so that it can be exported. These changes involve the reversal of flow in existing pipelines as well as the building of new pipelines.

An example of the first type of change is the 1.2 million barrel a day Capline pipeline that is owned by Marathon Pipe Line LLC, a unit of Marathon Petroleum (NYSE: MPC). In 1967, this pipeline began to ship imported oil northward from the Gulf Coast to Illinois and from there oil was dispensed to a number of Midwestern refineries.

But now, thanks to shale oil, that is no longer necessary and the flow has nearly dried up. But instead of shutting down the pipeline, Marathon is proposing to simply reverse the flow and send crude from places like North Dakota’s Bakken to reach Gulf Coast ports for export.

Of course, the most prolific field at the moment is the Permian Basin in Texas and New Mexico. Brand new pipelines – the BridgeTex, Permian Express and Cactus pipelines – now connect the Permian to the ports of Houston and Corpus Christi. The respective owners of these pipelines are:

  • BridgeTex is owned 50/50 by Magellan Midstream Partners L.P. (NYSE: MMP) and Plains All American Pipeline L.P. (NYSE: PAA).
  • Permian Express is controlled by Permian Express Partners, which is owned 85% by Energy Transfer Partners (NYSE: ETP) (after its merger with Sunoco Logistics Partners in April 2017) and 15% by Exxon Mobil (NYSE: XOM).
  • The Cactus pipeline is owned by the aforementioned Plains All American Pipeline.

And more pipelines are on the way. The energy consulting firm RBN estimates that a number of midstream projects (such as the Epic Pipeline, funded by private equity firm Ares Capital) could add 2 million to 2.1 million barrels a day in pipeline takeaway capacity from the Permian Basin. RBN believes that is “likely more than enough” to accommodate growing oil output from the Permian for the next five years.

Oil Pipeline Investments

Yet, despite all of this good news regarding the critical role pipelines play in the U.S. shale oil boom, the stocks of pipeline companies have been chronic underperformers. When U.S. oil prices collapsed from $100 a barrel in mid-2014 to a low of $26 a barrel in February 2016, the Alerian MLP index of pipeline companies (NYSE: AMLP) fell 60%. Oil has since more than doubled but the index has recovered only 27% as investors seem not to believe the recovery story.

This is understandable. Many energy master limited partnerships (MLPs) shifted towards financing growth from internal cash flow instead of raising money from capital markets. This policy resulted in slashed dividends – distributions grew by an average of only 1.5% in 2017 among the companies in the Alerian index. That was well below the 10-year average of 5.1%.

But still, with sentiment so low, I see the sector as a contrarian investment for you and one that is ripe for a rebound. The fund management company Pimco agrees with me. In a recent note to clients, it argued that by reducing dividends and leverage, the energy limited partnerships have been “healing” and their equity valuations “represent an overly negative outlook on the sector”.

My colleague Tim Plaehn writes about these energy MLPs quite often, so I urge you to check out his articles. But here are a few beaten-down ones that caught my eye.

The first MLP on my list is Energy Transfer Partners, with its wide geographic spread of pipelines. It should now begin reaping rewards from its major projects including Rover Pipeline, Bakken Pipeline and Permian Express 3. And its merger with Sunoco should lead to $200 million of cost savings by 2019. I also like its increasing cash distribution, which showed a year-over-year jump of over 40% in the recent quarter.

It still has a large amount of debt, but with the stock down more than 28% over the past year (though it’s little changed this year) it now may be worth your time to take a look.

The second MLP on my list is Plains All American, whose shares have fallen by nearly a third in the last year, but are up about 5% so far in 2018. The uptick may be due to investors seeing that the company is modifying the way it manages inventory and is implementing provisions in the contracts it signs that should reduce chronic earnings volatility.

A plus this year is that a number of its pipeline projects have, or will very soon, come online. These include the extensions of its Diamond Pipeline and BridgeTex Pipeline, which will be put into service during the first quarter of 2018. The company’s STACK JV Pipeline in already in service and the Cactus Pipeline project was completed at the end of 2017. Its Sunrise Pipeline Extension, approved during the third quarter of 2017, is expected to come online during the first half of 2019.

These pipeline additions should also add more stability to its earnings, again making it worthy of consideration by you.

Finally, for the broadest exposure, there is the aforementioned ETF (AMLP). But I personally prefer buying specific companies in this case.

Buffett just went all-in on THIS new asset. Will you?
Buffett could see this new asset run 2,524% in 2018. And he's not the only one... Mark Cuban says "it's the most exciting thing I've ever seen." Mark Zuckerberg threw down $19 billion to get a piece... Bill Gates wagered $26 billion trying to control it...
What is it?
It's not gold, crypto or any mainstream investment. But these mega-billionaires have bet the farm it's about to be the most valuable asset on Earth. Wall Street and the financial media have no clue what's about to happen...And if you act fast, you could earn as much as 2,524% before the year is up.
Click here to find out what it is.

Source: Investors Alley

The Simple Technical Indicator for Crypto

When crypto volatility is high (like it is now), buying coins can be intimidating.

How can the average person hope to time it right?

If you blindly guess, you may buy a cryptocurrency only to watch it drop 25% over the next week.

That’s why I use technical analysis (TA) to help time buys. It works perfectly well with cryptocurrencies.

The most commonly used TA tool in crypto, the relative strength index (RSI), is famous for its simplicity.

It’s a momentum indicator that uses a rating scale of 1 to 100.

  • Anything over 70 is overbought (expensive).
  • Anything under 30 is oversold (cheap).

RSI measures recent momentum, typically over a 14-day period. It gives you a very simple way to judge if a coin is relatively cheap or expensive.

Let’s take a look at a real-world example.

Over the last year, bitcoin has entered “oversold” territory three times (on a 12 month chart)…

  • July 16, 2017 – RSI hits 30, bitcoin price = $1,978 (pullback from $2,800)
  • September 14, 2017 – RSI hits 30, bitcoin price = $3,849 (pullback from $4,900)
  • February 6, 2018 – RSI hits 32, bitcoin price = $6,948 (pullback from $19,000).

As you can see, RSI can be a great tool for spotting dips in bitcoin. Here’s a partial chart showing the September 14 and February 6 “oversold” triggers…

As I write, on March 8, 2018, bitcoin has an RSI value of 42, meaning it’s neutral or slightly oversold at the moment.

Buying When It’s Terrifying

Buying crypto during a pullback can be hard to do. You know it’s a better time to buy than when the price is far higher, but all the news headlines are negative. For many people, it’s hard to pull the trigger in this environment.

By using a tool like RSI to gauge whether a coin is at a favorable price, we can remove the emotion from buying decisions.

You can make these types of charts for yourself at TradingView.com. You’ll need to sign up for a free account, then click the “Interactive Chart” button on the graph. Then under “Indicators,” select “Relative Strength Index.”

However, if you’re new to charting, realize that these tools aren’t magical, and that they take practice to use properly. It’s also important to know that the time period you’re looking at will affect the data. I’m a long-term investor, so I tend to look at longer periods (months or a year).

If you’re looking at a short-term chart, there will be more frequent “oversold” and “overbought” triggers. These can be useful if you don’t want to wait a long time before buying.

Due to recent increased market volatility, we’ll be paying more attention to the technical side of crypto over the coming weeks, especially in our Crypto Asset Strategies service. Keep an eye out for that.

It’s a fascinating area, and from what I’ve seen so far, TA may actually be more useful for crypto than it is for stocks.

I suspect the reason for this may be that a majority of stock volume these days is robo-trading (large algorithmic or “quant” funds), while the crypto market is still an organic market driven mainly by supply and demand… and decisions made by individuals.

Most technical analysis models are based on historical investor behavior, so it makes sense that they’d work well in a “pure” market like crypto but not as much in today’s robo-dominated, interest-rate-sensitive stock market.

Do you have any favorite technical indicators you use for crypto? Let us know in the comments.

Good investing,

Adam Sharp
Co-Founder, Early Investing

Can a $10 Bill Really Fund Your Retirement? The digital currency markets are delivering profits unlike anything we’ve ever seen. ​23 recently doubled in a single week. And some like DubaiCoin have jumped as much as 8,200X in value in 18 months. It’ unprecedented... but you won’t receive any of the rewards unless you put a little money in the game. Find out how $10 could make you rich HERE. ​



Source: Early Investing